NPO Microgen - the leading manufacturer of vaccines and immunobiological drugs in Russia

MICROGEN is Russia's largest producer of immunobiological products, one of the three largest pharmaceutical companies in Russia. According to Russian Minister of Health, Veronika Skvortsova, Microgen has a strategic importance for Russia's national security.

MICROGEN was established in May 2003 as a result of the merger of state-owned enterprises producing medical immunobiological products and other medical drugs. Following a decision of the Russian Government, the Company was created “to satisfy the country's needs in preventive, diagnostic and therapeutic immunobiological preparations”.

At the moment, the Company includes nine branches located throughout the country and employs more than 5 thousand people, including 7 Doctors of Sciences, 3 Professors and 104 PhDs.

The priority area of business is the production of vaccines against dangerous infectious diseases, including the vaccines from the National Vaccination Schedule.

Some of the MICROGEN’s subsidiaries have over a 100-year history. They develop and produce vaccines and toxoids, blood products, bacteriophages, diagnostic preparations, culture media, and allergens.

MICROGEN's leading industrial enterprises are Virion (Tomsk), Immunopreparat (Ufa), Allergen (Stavropol), Biomed (Perm), ImBio (Nizhny Novgorod), Moscow division of Bacterial Agents, Irkutsk Plant of Bacterial Agents.